NCT00810771

Brief Summary

The goal of this study is to evaluate whether an educational tool about colorectal cancer (CRC) completed on a computer that helps patients clarify their CRC screening preferences will lead to increased screening rates for CRC compared to standard information delivered via computer.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
466

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Feb 2009

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 16, 2008

Completed
2 days until next milestone

First Posted

Study publicly available on registry

December 18, 2008

Completed
2 months until next milestone

Study Start

First participant enrolled

February 1, 2009

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2012

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2012

Completed
2.8 years until next milestone

Results Posted

Study results publicly available

June 2, 2015

Completed
Last Updated

June 2, 2015

Status Verified

June 1, 2015

Enrollment Period

3.2 years

First QC Date

December 16, 2008

Results QC Date

March 26, 2015

Last Update Submit

June 1, 2015

Conditions

Keywords

Hospitals, VeteransMass Screening/utilizationPatient PreferencePrevention & ControlEpidemiology

Outcome Measures

Primary Outcomes (1)

  • Colorectal Cancer (CRC) Screening Rate.

    The CRC Screening rate reports percentage of participant adherence with any Colorectal Cancer Screening test within 6 months of Decider Guider intervention. Decider Guider is a tool to help patients make an informed choice about colon cancer testing.

    Within 6 months of Decider Guider intervention.

Secondary Outcomes (6)

  • Number of Elements of Braddock's Informed Decision Making (IDM) Model Discussed With Provider

    3-5 days after Decider Guider intervention

  • Colorectal Cancer Screening (CRCS) Knowledge and Attitudes.

    3-5 days after Decider Guider intervention.

  • Decisional Satisfaction

    3-5 days after Decider Guider intervention.

  • Intent to Get Colorectal Cancer Screening.

    3-5 days after Decider Guider intervention.

  • Self Efficacy.

    3-5 days after Decider Guider intervention.

  • +1 more secondary outcomes

Study Arms (3)

Preference-tailored (PT) intervention

EXPERIMENTAL

Intervention: Behavioral: Standard Information Behavioral: Preference-tailored Information

Behavioral: Standard InformationBehavioral: Preference-tailored Information

Standard information (SI) intervention

ACTIVE COMPARATOR

Behavioral: Standard Information

Behavioral: Standard Information

Usual Care

NO INTERVENTION

Due to budget and time constraints this group was not powered as a true study arm but was used to assess the impact of our baseline physician information letter and to control for any other interventions of system-wide initiatives that may occur during the study timeframe and impact rated of CRC screening. Data was not collected on every participant in this arm.

Interventions

A computer based educational overview of CRC and CRC test options will be presented to the subject. The subject will be given a handout with a brief description of each of the screening options and will include the test that they have chosen as their preferred test. The subjects will be asked to take this handout to their upcoming clinic appointment and to discuss the screening options with their care provider.

Preference-tailored (PT) interventionStandard information (SI) intervention

A preference elicitation exercise that will generate a list of the three top attributes for the subject and the CRC screening test most consistent with these attributes. Subjects will be provided with a handout to take to their clinic appointment as the Standard Information group does, but with the addition of a listing of their top attributes and the test most consistent with their top attributes.

Preference-tailored (PT) intervention

Eligibility Criteria

Age50 Years - 78 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Clinic appointment at Ann Arbor or Pittsburgh VA during recruitment period.
  • Age 50-78.
  • Not up to date with CRC screening according to VA and USPSTF guidelines.
  • At average risk for CRC (no history of CRC, adenomatous colon polyps, inflammatory bowel disease, and no family history of CRC).
  • Has current address and telephone number listed in medical record.

You may not qualify if:

  • DNR/DNI code status.
  • Metastatic cancer.
  • Stage D congestive heart failure.
  • Severe COPD.
  • Coronary artery disease (CAD) and MI within one year or CAD and unstable angina within 6 months.
  • Dementia.
  • Inability to conduct activities of daily living.
  • Life expectancy less than one year.
  • Other - anything else that limits CRC screening options.
  • Scheduled for a colonoscopy, sigmoidoscopy, DCBE, or CTC.
  • prior participation in this study
  • unable to contact after 2 introductory letters (at least 6 months apart)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

VA Ann Arbor Healthcare System

Ann Arbor, Michigan, 48113-0170, United States

Location

Center for Health Equity Research and Promotion

Pittsburgh, Pennsylvania, 15240, United States

Location

MeSH Terms

Conditions

Colorectal NeoplasmsPatient Acceptance of Health CarePatient Preference

Condition Hierarchy (Ancestors)

Intestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesRectal DiseasesTreatment Adherence and ComplianceHealth BehaviorBehaviorPatient Satisfaction

Limitations and Caveats

Usual care arm was not true 3rd arm. We identified pts meeting eligibility criteria \& randomized \~ 10th pt to be followed, measuring CRC screening 6 mos later. No intervention or survey. Only 79.6% of those enrolled completed survey.

Results Point of Contact

Title
Sarah Hawley, Ph.D.
Organization
VA Ann Arbor Healthcare System, Center for Clinical Management Research

Study Officials

  • Sarah T Hawley, PhD MPH BA

    Ann Arbor VA Medical Center

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 16, 2008

First Posted

December 18, 2008

Study Start

February 1, 2009

Primary Completion

May 1, 2012

Study Completion

August 1, 2012

Last Updated

June 2, 2015

Results First Posted

June 2, 2015

Record last verified: 2015-06

Locations